ArriVent BioPharma, Inc. Common StockAVBPNASDAQ
Loading
Profit from core business operations before interest and taxes
Latest
$-177.53M
↓ 126% vs avg
Percentile
P0
Near historical low
Streak
4 yr
Consecutive declineContracting
Average
$-78.41M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-177.53M | -88.2% |
| 2024 | $-94.31M | -26.4% |
| 2023 | $-74.59M | -102.1% |
| 2022 | $-36.91M | -324.4% |
| 2021 | $-8.70M | - |